logo


Date:July 12, 2012

Michael Scheurer, Ph.D., M.P.H.

Michael Scheurer, Ph.D., M.P.H.Director, Childhood Cancer Epidemiology and Prevention Program

Associate Professor
Department of Pediatrics
Section of Hematology-Oncology
Baylor College of Medicine

Adjunct Assistant Professor
Department of Epidemiology
The University of Texas M. D. Anderson Cancer Center

Dr. Michael Scheurer
One Baylor Plaza, MS-BCM305
Houston, TX 77030

Phone: 713-798-5547
Fax: 713-798-8711
Email: scheurer@bcm.edu

Biography

Dr. Michael Scheurer is a Molecular Epidemiologist and Director of the Childhood Cancer Epidemiology and Prevention Center of the Texas Children’s Cancer Center and in the Cancer Prevention and Population Sciences Program of the Dan L. Duncan Cancer Center.

Dr. Michael Scheurer’s research focuses on viruses and immune function as risk factors for cancer development and progression.

His laboratory looks for novel ways to identify and catalog molecular markers of viral infection, including host-virus interactions, as risk factors for the development of cancer. He is actively involved with two large international research groups focused on two rare tumors: the Brain Tumor Epidemiology Consortium and the Childhood Leukemia International Consortium.

Dr. Scheurer is currently working with other researchers and clinicians at Texas Children’s Cancer Center to develop a state-wide study to examine risk factors for childhood brain tumors. He also currently has a research project examining Human papillomavirus (HPV)-associated cancers, in particular cervical cancer, including the examination of the HPV vaccine and its effects on cancer incidence. He has an increasing program looking at Human cytomegalovirus (HCMV) and host immune function in relation to pediatric and adult brain tumors, and he also has an interest in the factors that contribute to the poor prognosis and outcome for brain tumor patients, including neurocognitive decline and other therapy-related toxicities.

Dr.. Michael Scheurer is a member of the Childhood Cancer Epidemiology and Prevention Program.

Education

B.S., Biological Sciences/Anthropology, University of Alabama
M.P.H., Epidemiology, University of Alabama at Birmingham
Ph.D., Epidemiology, University of Texas School of Public Health at Houston
Postdoctoral Fellowship, Molecular Epidemiology, The University of Texas M. D. Anderson Cancer Center

Selected Memberships

Member, American Public Health Association
Member, International Papillomavirus Society
Member, American Association for Cancer Research (AACR)
Member, American Statistical Association
Member, American Society of Preventive Oncology
Member, Society for Epidemiologic Research
Member, Society for Neuro-Oncology
Member, Brain Tumor Epidemiology Consortium

Research Interests

Viruses and immune function risk factors for cancer development
Molecular Epidemiology
Molecular markers of viral infection
Host-virus interactions
Risk factors for childhood brain tumors
Human papillomavirus (HPV)-associated cancers, in particular cervical cancer
Factors that contribute to poor prognosis and outcome in brain tumor patients

Research

Our lab examines viruses and immune function as risk factors for cancer development and progression/outcome. Our research looks for novel ways to identify and catalog molecular markers of viral infection, including host-virus interactions, as risk factors for the development of cancer. Much of this work has focused on Human papillomavirus (HPV) and Human cytomegalovirus (HCMV); however, we are currently expanding those efforts to include Human herpesvirus (HHV) 6. We also examine genetic variants related to inflammation and infection that might increase risk for cancer development or progression.

We are actively involved with two large international research groups focused on two rare tumors: the Brain Tumor Epidemiology Consortium and the Childhood Leukemia International Consortium. We are also involved with a large Program Project Grant evaluating novel imaging technology for the detection of HPV-related cervical cancer and precancer.

The final aspect of our research program examines factors that contribute to the poor prognosis and outcome for brain tumor and pediatric leukemia patients, including neurocognitive decline and other therapy-related toxicities.

Laboratory Members

Principal Investigator

Michael Scheurer, Ph.D., M.P.H.

Postdoctoral Associate

E. Susan Amirian, Ph.D.

Postdoctoral Fellow

Hung N. Luu, M.D., M.P.H.

Senior Research Assistant

Deborah Marquez-Do

Research Coordinator II

J.D. Franklin
Valentina Montoya